Showing 20 of 10123 recruiting trials
RecruitingNCT07470320 ↗
Placental Biology in Health and Disease
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
👨⚕️ Salah-Eddin Al-Batran, Prof. Dr., Frankfurter Institut für Klinische Krebsforschung IKF GmbH📍 2 sites📅 Started Dec 2025View details ↗
RecruitingNCT07505797 ↗
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia
RecruitingNCT07373639 ↗
A Long-term Follow-up Study in Patients Who Received BEAM-101
Sapu003 in Advanced mTOR-sensitive Solid Tumors
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
👨⚕️ Mengtao Li, PhD, Peking Union Medical College Hospital📍 3 sites📅 Started Dec 2025View details ↗
Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma
👨⚕️ Florian Lordick, Prof. Dr., Universitätsklinikum Leipzig📍 4 sites📅 Started Dec 2025View details ↗
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →